Aptamer Inhibits Degradation of Platelet Proteolytically Activatable Receptor, PAR-1, by Thrombin

By Boncler M.A.   Koziolkiewicz M.   Watala C.  

Thrombosis Research, Vol. 104, Iss. 3, 2001-11 ,pp. : 215-222

Elsevier

Access to resources Recommend Favorite

Thrombin inhibition by HCII in the presence of elastase-cleaved HCII and thrombin-HCII complex

By Maekawa H.   Sato H.   Tollefsen D.M.  

Thrombosis Research, Vol. 100, Iss. 5, 2000-12 ,pp. : 443-451

Elsevier

Access to resources Recommend Favorite

Chemical Sulfonation and Anticoagulant Activity of Acharan Sulfate - Antithrombin III-and heparin cofactor II-independent inhibition of factor X activation by factor IXa-Factor VIIIa complex and heparin cofactor II-dependent inhibition of thrombin

By Wu S.J.   Chun M.W.   Shin K.H.   Toida T.   Park Y.   Linhardt R.J.   Kim Y.S.  

Thrombosis Research, Vol. 92, Iss. 6, 1998-12 ,pp. : 273-281

Elsevier

Access to resources Recommend Favorite

COMPARATIVE ANTICOAGULANT EFFECTS OF VARIOUS THROMBIN INHIBITORS, AS DETERMINED IN THE ECARIN CLOTTING TIME METHOD

By Callas D.D.   Fareed J.  

Thrombosis Research, Vol. 83, Iss. 6, 1996-09 ,pp. : 463-468

Elsevier

Access to resources Recommend Favorite

Inhibition of Arterial Thrombosis by a Peptide Ligand of the Thrombin Receptor

By Pakala R.   Liang C.T.   Benedict C.R.  

Thrombosis Research, Vol. 100, Iss. 1, 2000-10 ,pp. : 89-96

Elsevier

Access to resources Recommend Favorite